The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature

Roberta Angelico, Francesca Blasi, Tommaso Maria Manzia, Luca Toti, Giuseppe Tisone, Roberto Cacciola, Roberta Angelico, Francesca Blasi, Tommaso Maria Manzia, Luca Toti, Giuseppe Tisone, Roberto Cacciola

Abstract

Background and Objectives: In the era of the coronavirus disease 2019 (COVID-19) pandemic, the management of immunosuppressive (IS) therapy in kidney transplant (KT) recipients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires attention. It is not yet understood whether IS therapy may protect from the cytokine storm induced by SARS-CoV-2 infection or a temporary adjustment/withdrawal of IS therapy to restore the immune system may be necessary. We performed a systematic literature review to investigate the current management of IS therapy in KT recipients with COVID-1. Materials and Methods: Out of 71 articles published from 1 February 2020 until 30 October 2020, 554 KT recipients with SARS-CoV-2 infection were identified. Results: Modifications of IS therapy were based on the clinical conditions. For asymptomatic patients or those with mild COVID-19 symptoms, a "wait and see approach" was mostly used; a suspension of antimetabolites drugs (347/461, 75.27%) or mTOR inhibitors (38/48, 79.2%) was adopted in the majority of patients with symptomatic COVID-19 infections. For CNIs, the most frequent attitude was their maintenance (243/502, 48.4%) or dose-reduction (99/502, 19.72%) in patients asymptomatic or with mild COVID-19 symptoms, while drug withdrawal was the preferred choice in severely symptomatic patients (160/450, 31.87%). A discontinuation of all IS drugs was used only in severely symptomatic COVID-19 patients on invasive mechanical ventilation. Renal function remained stable in 422(76.17%) recipients, while 49(8.84%) patients experienced graft loss. Eight (1.44%) patients experienced a worsening of renal function. The overall mortality was 21.84%, and 53(9.56%) patients died with functioning grafts. Conclusion: A tailored approach to the patient has been the preferred strategy for the management of IS therapy in KT recipients, taking into account the clinical conditions of patients and the potential interactions between IS and antiviral drugs, in the attempt to balance the risks of COVID-19-related complications and those due to rejection or graft loss.

Keywords: allograft outcomes; complications; coronavirus disease 2019; immunosuppression; kidney transplantation; patient outcomes; severe acute respiratory syndrome coronavirus 2.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the literature search and study selection.

References

    1. Wolfe R.A., Roys E.C., Merion R.M. Trends in Organ Donation and Transplantation in the United States, 1999–2008. Am. J. Transplant. 2010;10 Pt 2:961–972. doi: 10.1111/j.1600-6143.2010.03021.x.
    1. Favi E., Salerno M., Romagnoli J., Castagneto M., Citterio F. Significant Improvement in Patient Survival After Renal Transplantation in the Last Decade. Transplant. Proc. 2011;43:285–287. doi: 10.1016/j.transproceed.2010.09.105.
    1. Howard R.J., Patton P.R., Reed A.I., Hemming A.W., Van Der Werf W.J., Pfaff W.W., Srinivas T.R., Scornik J.C. The changing causes of graft loss and death after kidney transplantation. Transplantation. 2002;73:1923–1928. doi: 10.1097/00007890-200206270-00013.
    1. Pruthi R., Steenkamp R., Feest T. UK Renal Registry 16th Annual Report: Chapter 8 Survival and Cause of Death of UK Adult Patients on Renal Replacement Therapy in 2012: National and Centre-specific Analyses. Nephron Clin. Pr. 2013;125:139–169. doi: 10.1159/000360027.
    1. Lovato A., De Filippis C., Marioni G. Upper airway symptoms in coronavirus disease 2019 (COVID-19) Am. J. Otolaryngol. 2020;41:102474. doi: 10.1016/j.amjoto.2020.102474.
    1. Monaco A., Manzia T.M., Angelico R., Iaria G., Gazia C., Al Alawi Y., Fourtounas K., Tisone G., Cacciola R. Awareness and Impact of Non-pharmaceutical Interventions During Coronavirus Disease 2019 Pandemic in Renal Transplant Recipients. Transplant. Proc. 2020;52:2607–2613. doi: 10.1016/j.transproceed.2020.07.010.
    1. Centers for Disease Control nd Prevention People with Underying Medical Conditions, Immunocompromides State (Weakened Immune System) from Solid Organ Transplant. [(accessed on 20 March 2021)];2020 Available online: .
    1. Maggiore U., Abramowicz D., Crespo M., Mariat C., Mjoen G., Peruzzi L., Sever M.S., Oniscu G.C., Hilbrands L., Watschinger B. How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion. Nephrol. Dial. Transplant. 2020;35:899–904. doi: 10.1093/ndt/gfaa130.
    1. Kasiske B.L., Zeier M.G., Chapman J.R., Craig J.C., Ekberg H., Garvey C.A., Green M.D., Jha V., Josephson M.A., Kiberd B.A., et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int. 2010;77:299–311. doi: 10.1038/ki.2009.377.
    1. Moher D., Liberati A., Tetzlaff J., Altman D.G., The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097.
    1. Akdur A., Karakaya E., Soy E.H.A., Alshalabi O., Kırnap M., Arslan H., Ulubay G., Hekimoglu K., Moray G., Haberal M. Coronavirus Disease (COVID-19) in Kidney and Liver Transplant Patients: A Single-Center Experience. Exp. Clin. Transplant. 2020;18:270–274. doi: 10.6002/ect.2020.0193.
    1. Allam S.R., Dao A., Madhrira M.M., Antiporta P.B., Nair R.R., Guiteau J.J., Reyad A.I. Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient. Transpl. Infect. Dis. 2020;22:e13326. doi: 10.1111/tid.13326.
    1. Bartiromo M., Borchi B., Botta A., Bagalà A., Lugli G., Tilli M., Cavallo A., Xhaferi B., Cutruzzulà R., Vaglio A., et al. Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19) Transpl. Infect. Dis. 2020;22:e13286. doi: 10.1111/tid.13286.
    1. Billah M., Santeusanio A., Delaney V., Cravedi P., Farouk S.S. A catabolic state in a kidney transplant recipient with COVID-19. Transpl. Int. 2020;33:1140–1141. doi: 10.1111/tri.13635.
    1. Bussalino E., De Maria A., Russo R., Paoletti E. Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report. Am. J. Transplant. 2020;20:1922–1924. doi: 10.1111/ajt.15920.
    1. Chen S., Yin Q., Shi H., Du D., Chang S., Ni L., Qiu H., Chen Z., Zhang J., Zhang W. A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China. Am. J. Transplant. 2020;20:1869–1874. doi: 10.1111/ajt.15903.
    1. Cheng D., Wen J., Liu Z., Lv T., Chen J. Coronavirus disease 2019 in renal transplant recipients: Report of two cases. Transpl. Infect. Dis. 2020;22:e13329. doi: 10.1111/tid.13329.
    1. Chenna A., Konala V.M., Gayam V., Naramala S., Adapa S. Coronavirus Disease 2019 (COVID-19) in a Renal Transplant Patient. Cureus. 2020;12:e8038. doi: 10.7759/cureus.8038.
    1. Mathiasen V.D., Jensen-Fangel S., Skov K., Leth S. Uneventful case of COVID-19 in a kidney transplant recipient. BMJ Case Rep. 2020;13:e237427. doi: 10.1136/bcr-2020-237427.
    1. Dirim A.B., Demir E., Ucar A.R., Garayeva N., Safak S., Oto O.A., Yazici H., Alibeyoglu A.M., Orhun G., Cagatay A.A., et al. Fatal SARS-CoV-2 infection in a renal transplant recipient. CEN Case Rep. 2020;9:409–412. doi: 10.1007/s13730-020-00496-4.
    1. Fontana F., Alfano G., Mori G., Amurri A., Tei L., Ballestri M., Leonelli M., Facchini F., Damiano F., Magistroni R., et al. COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine. Am. J. Transplant. 2020;20:1902–1906. doi: 10.1111/ajt.15935.
    1. Gandolfini I., Delsante M., Fiaccadori E., Zaza G., Manenti L., Degli Antoni A., Peruzzi L., Riella L.V., Cravedi P., Maggiore U. COVID-19 in kidney transplant recipients. Am. J. Transplant. 2020;20:1941–1943. doi: 10.1111/ajt.15891.
    1. Guillen E., Pineiro G.J., Revuelta I., Rodriguez D., Bodro M., Moreno A., Campistol J.M., Diekmann F., Ventura-Aguiar P. Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? Am. J. Transplant. 2020;20:1875–1878. doi: 10.1111/ajt.15874.
    1. Ahmad S.H., Smith R., Camilleri B. Belatacept, kidney transplantation and COVID-19: Successful management of the first reported case within the United Kingdom. Clin. Transplant. 2020;34:e14026. doi: 10.1111/ctr.14026.
    1. Hsu J.J., Gaynor P., Kamath M., Fan A., Al-Saffar F., Cruz D., Nsair A. COVID-19 in a high-risk dual heart and kidney transplant recipient. Am. J. Transplant. 2020;20:1911–1915. doi: 10.1111/ajt.15936.
    1. Huang J., Lin H., Wu Y., Fang Y., Kumar R., Chen G., Lin S. COVID-19 in posttransplant patients—Report of 2 cases. Am. J. Transplant. 2020;20:1879–1881. doi: 10.1111/ajt.15896.
    1. Jiang J., Miao Y., Zhao Y., Lu X., Zhou P., Zhou X., Chen Z., Du D. Convalescent plasma therapy: Helpful treatment of COVID-19 in a kidney transplant recipient presenting with severe clinical manifestations and complex complications. Clin. Transplant. 2020;34:e14025. doi: 10.1111/ctr.14025.
    1. Kates O.S., Fisher C.E., Stankiewicz-Karita H.C., Shepherd A.K., Church E.C., Kapnadak S.G., Lease E.D., Riedo F.X., Rakita R.M., Limaye A.P. Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States. Am. J. Transplant. 2020;20:1885–1890. doi: 10.1111/ajt.15944.
    1. Kemmner S., Guba M.O., Schönermarck U., Stangl M., Fischereder M. Cyclosporine as a preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection. Kidney Int. 2020;98:507–508. doi: 10.1016/j.kint.2020.05.024.
    1. Kim Y., Kwon O., Paek J.H., Park W.Y., Jin K., Hyun M., Lee J.Y., Kim H.A., Han S. Two distinct cases with COVID-19 in kidney transplant recipients. Am. J. Transplant. 2020;20:2269–2275. doi: 10.1111/ajt.15947.
    1. Kocak B., Arpali E., Akyollu B., Yelken B., Tekin S., Kanbay M., Turkmen A., Kalayoglu M. Oligosymptomatic Kidney Transplant Patients With COVID-19: Do They Pose a Risk to Other Recipients? Transplant. Proc. 2020;52:2663–2666. doi: 10.1016/j.transproceed.2020.05.028.
    1. Kolonko A., Dudzicz S., Wiecek A., Król R. COVID-19 infection in solid organ transplant recipients: A single-center experience with patients immediately after transplantation. Transpl. Infect. Dis. 2021;23:e13381. doi: 10.1111/tid.13381.
    1. Kumar R.N., Tanna S.D., Shetty A.A., Stosor V. COVID-19 in an HIV-positive kidney transplant recipient. Transpl. Infect. Dis. 2020;22:e13338. doi: 10.1111/tid.13338.
    1. Lauterio A., Valsecchi M., Santambrogio S., De Carlis R., Merli M., Calini A., Centonze L., Buscemi V., Bottiroli M., Puoti M., et al. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab. Transpl. Infect. Dis. 2020;22:e13334. doi: 10.1111/tid.13334.
    1. Li Q., Cheng Q., Zhao Z., Dai N., Zeng L., Zhu L., Guo W., Li C., Wang J., Li S., et al. Novel coronavirus infection and acute kidney injury in two renal transplant recipients: A case report. J. Int. Med. Res. 2020;48:300060520964009. doi: 10.1177/0300060520964009.
    1. Ma B.M., Hung I.F.N., Chan G.C.W., Tam A.R., Chan S.S.K., Wong B.C.K., Fukuda K., Ohno T., Yuen K.Y., Chan T.M. Case of “relapsing” COVID-19 in a kidney transplant recipient. Nephrology. 2020;25:933–936. doi: 10.1111/nep.13786.
    1. Machado D.J.D.B., Ianhez L.E. COVID-19 pneumonia in kidney transplant recipients—Where we are? Transpl. Infect. Dis. 2020;22:e13306. doi: 10.1111/tid.13306.
    1. Man Z., Jing Z., Huibo S., Bin L., Fanjun Z. Viral shedding prolongation in a kidney transplant patient with COVID-19 pneumonia. Am. J. Transplant. 2020;20:2626–2627. doi: 10.1111/ajt.15996.
    1. Marx D., Moulin B., Fafi-Kremer S., Benotmane I., Gautier G., Perrin P., Caillard S. First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am. J. Transplant. 2020;20:1944–1946. doi: 10.1111/ajt.15919.
    1. Meziyerh S., Zwart T.C., Van Etten R.W., Janson J.A., Van Gelder T., Alwayn I.P.J., De Fijter J.W., Reinders M.E.J., Moes D.J.A.R., De Vries A.P. Severe COVID-19 in a renal transplant recipient: A focus on pharmacokinetics. Am. J. Transplant. 2020;20:1896–1901. doi: 10.1111/ajt.15943.
    1. Namazee N., Mahmoudi H., Afzal P., Ghaffari S. Novel coronavirus 2019 pneumonia in a kidney transplant recipient. Am. J. Transplant. 2020;20:2599–2601. doi: 10.1111/ajt.15999.
    1. Ning L., Liu L., Li W., Liu H., Wang J., Yao Z., Zhang S., Zhao D., Nashan B., Shen A., et al. Novel coronavirus (SARS-CoV-2) infection in a renal transplant recipient: Case report. Am. J. Transplant. 2020;20:1864–1868. doi: 10.1111/ajt.15897.
    1. Sakulkonkij P., Bruminhent J., Pankongngam C., Chalermphunchai N. A family cluster of diagnosed coronavirus disease 2019 (COVID-19) kidney transplant recipient in Thailand. Immun. Inflamm. Dis. 2020;8:534–543. doi: 10.1002/iid3.337.
    1. Seminari E., Colaneri M., Sambo M., Gallazzi I., Di Matteo A., Roda S., Bruno R., the COVID19 IRCCS San Matteo Pavia Task Force SARS Cov-2 infection in a renal-transplanted patient: A case report. Am. J. Transplant. 2020;20:1882–1884. doi: 10.1111/ajt.15902.
    1. Shingare A., Bahadur M.M., Raina S. COVID-19 in recent kidney transplant recipients. Am. J. Transplant. 2020;20:3206–3209. doi: 10.1111/ajt.16120.
    1. Antony S.J., Singh J., De Jesus M., Lance J. Early use of tocilizumab in respiratory failure associated with acute COVID -19 pneumonia in recipients with solid organ transplantation. IDCases. 2020;21:e00888. doi: 10.1016/j.idcr.2020.e00888.
    1. Suwanwongse K., Shabarek N. Fatal Outcome in a Kidney-Pancreas Transplant Recipient With COVID-19. Cureus. 2020;12:e8691. doi: 10.7759/cureus.8691.
    1. Tanaka R., Kakuta Y., Tsutahara K., Nakagawa M., Ichimaru N., Sakaguchi K., Kato T., Imamura R., Nonomura N., Takao T. Successful recovery from coronavirus disease 2019 in a living kidney transplant recipient using low-dose methylprednisolone. IJU Case Rep. 2021;4:22–24. doi: 10.1002/iju5.12226.
    1. Tantisattamo E., Reddy U.G., Duong D.K., Ferrey A.J., Ichii H., Dafoe D.C., Kalantar-Zadeh K. Hyponatremia: A possible immuno-neuroendocrine interface with COVID-19 in a kidney transplant recipient. Transpl. Infect. Dis. 2020;22:e13355. doi: 10.1111/tid.13355.
    1. Thammathiwat T., Tungsanga S., Tiankanon K., Torvorapanit P., Chumpangern W., Udomkarnjananun S., Avihingsanon Y., Sriprasart T., Srisawat N., Jutivorakool K., et al. A case of successful treatment of severe COVID-19 pneumonia with favipiravir and tocilizumab in post–kidney transplant recipient. Transpl. Infect. Dis. 2021;23:e13388. doi: 10.1111/tid.13388.
    1. Tzukert K., Abel R., Levi I.M.Y., Gork I., Orpaz L.Y., Azmanov H., Elhalel M.D. The Challenge of Treating Kidney Transplant Recipients Infected with COVID-19: Report of the First Cases in Israel. Isr. Med. Assoc. J. 2020;22:602–604.
    1. Velioglu A., Tuglular S. Care of asymptomatic SARS-CoV-2 positive kidney transplant recipients. Transpl. Int. 2020;33:1331–1332. doi: 10.1111/tri.13691.
    1. Wang J., Li X., Cao G., Wu X., Wang Z., Yan T. COVID-19 in a Kidney Transplant Patient. Eur. Urol. 2020;77:769–770. doi: 10.1016/j.eururo.2020.03.036.
    1. Wang A.X., Cardona O.Q., Ho D.Y., Busque S., Lenihan C.R. Influence of immunosuppression on seroconversion against SARS-CoV-2 in two kidney transplant recipients. Transpl. Infect. Dis. 2021;23:e13423. doi: 10.1111/tid.13423.
    1. Xu J.J., Samaha D., Mondhe S., Massicotte-Azarniouch D., Knoll G., Ruzicka M. Renal infarct in a COVID-19–positive kidney–pancreas transplant recipient. Am. J. Transplant. 2020;20:3221–3224. doi: 10.1111/ajt.16089.
    1. Zhong Z., Zhang Q., Xia H., Wang A., Liang W., Zhou W., Zhou L., Liu X., Rao L., Li Z., et al. Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients. Am. J. Transplant. 2020;20:1916–1921. doi: 10.1111/ajt.15928.
    1. Zhu L., Shu H., Li H., Qiu T., Zhou J., Chen G. Slow Recovery from Critical Coronavirus Disease 2019 Pneumonia in an Immunosuppressed Renal Transplant Recipient with Early Acute Cardiorenal Syndrome. Cardiorenal Med. 2020;10:470–475. doi: 10.1159/000510916.
    1. Zhu L., Xu X., Ma K., Yang J., Guan H., Chen S., Chen Z., Chen G. Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression. Am. J. Transplant. 2020;20:1859–1863. doi: 10.1111/ajt.15869.
    1. Akalin E., Azzi Y., Bartash R., Seethamraju H., Parides M., Hemmige V., Ross M., Forest S., Goldstein Y.D., Ajaimy M., et al. Covid-19 and Kidney Transplantation. N. Engl. J. Med. 2020;382:2475–2477. doi: 10.1056/NEJMc2011117.
    1. Alberici F., Delbarba E., Manenti C., Econimo L., Valerio F., Pola A., Maffei C., Possenti S., Zambetti N., Moscato M., et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. 2020;97:1083–1088. doi: 10.1016/j.kint.2020.04.002.
    1. Banerjee D., Popoola J., Shah S., Ster I.C., Quan V., Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020;97:1076–1082. doi: 10.1016/j.kint.2020.03.018.
    1. Bösch F., Börner N., Kemmner S., Lampert C., Jacob S., Koliogiannis D., Stangl M., Michel S., Kneidinger N., Schneider C., et al. Attenuated early inflammatory response in solid organ recipients with COVID-19. Clin. Transplant. 2020;34:e14027. doi: 10.1111/ctr.14027.
    1. Chen T.Y., Farghaly S., Cham S., Tatem L.L., Sin J.H., Rauda R., Ribisi M., Sumrani N. COVID-19 pneumonia in kidney transplant recipients: Focus on immunosuppression management. Transpl. Infect. Dis. 2020;22:e13378. doi: 10.1111/tid.13378.
    1. The Columbia University Kidney Transplant Program Early Description of Coronavirus 2019 Disease in Kidney Transplant Recipients in New York. J. Am. Soc. Nephrol. 2020;31:1150–1156. doi: 10.1681/ASN.2020030375.
    1. Crespo M., Pérez-Sáez M.J., Redondo-Pachón D., Llinàs-Mallol L., Montero M.M., Villar-García J., Arias-Cabrales C., Buxeda A., Burballa C., Vázquez S., et al. COVID-19 in elderly kidney transplant recipients. Am. J. Transplant. 2020;20:2883–2889. doi: 10.1111/ajt.16096.
    1. Devresse A., Belkhir L., Vo B., Ghaye B., Scohy A., Kabamba B., Goffin E., De Greef J., Mourad M., De Meyer M., et al. COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium. Kidney Med. 2020;2:459–466. doi: 10.1016/j.xkme.2020.06.001.
    1. Elias M., Pievani D., Randoux C., Louis K., Denis B., DeLion A., Le Goff O., Antoine C., Greze C., Pillebout E., et al. COVID-19 Infection in Kidney Transplant Recipients: Disease Incidence and Clinical Outcomes. J. Am. Soc. Nephrol. 2020;31:2413–2423. doi: 10.1681/ASN.2020050639.
    1. Fernández-Ruiz M., Andrés A., Loinaz C., Delgado J.F., López-Medrano F., Juan R.S., González E., Polanco N., Folgueira M.D., Lalueza A., et al. COVID-19 in solid organ transplant recipients: A single-center case series from Spain. Am. J. Transplant. 2020;20:1849–1858. doi: 10.1111/ajt.15929.
    1. Fung M., Chiu C.Y., DeVoe C., Doernberg S.B., Schwartz B.S., Langelier C., Henrich T.J., Yokoe D., Davis J., Hays S.R., et al. Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States. Am. J. Transplant. 2020;20:3225–3233. doi: 10.1111/ajt.16079.
    1. Hartzell S., Bin S., Benedetti C., Haverly M., Gallon L., Zaza G., Riella L.V., Menon M.C., Florman S., Rahman A.H., et al. Evidence of potent humoral immune activity in COVID-19-infected kidney transplant recipients. Am. J. Transplant. 2020;20:16261. doi: 10.1111/ajt.16261.
    1. Lubetzky M., Aull M.J., Craig-Schapiro R., Lee J.R., Marku-Podvorica J., Salinas T., Gingras L., Lee J.B., Sultan S., Kodiyanplakkal R.P., et al. Kidney allograft recipients, immunosuppression, and coronavirus disease-2019: A report of consecutive cases from a New York City transplant center. Nephrol. Dial. Transplant. 2020;35:1250–1261. doi: 10.1093/ndt/gfaa154.
    1. Maritati F., Cerutti E., Zuccatosta L., Fiorentini A., Finale C., Ficosecco M., Cristiano F., Capestro A., Balestra E., Taruscia D., et al. SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region. Transpl. Infect. Dis. 2020;22:e13377. doi: 10.1111/tid.13377.
    1. Mehta S.A., Leonard J., Labella P., Cartiera K., Soomro I., Neumann H., Montgomery R.A., Ali N.M. Outpatient management of kidney transplant recipients with suspected COVID-19—Single-center experience during the New York City surge. Transpl. Infect. Dis. 2020;22:e13383. doi: 10.1111/tid.13383.
    1. Mella A., Mingozzi S., Gallo E., Lavacca A., Rossetti M., Clari R., Randone O., Maffei S., Salomone M., Imperiale D., et al. Case series of six kidney transplanted patients with COVID-19 pneumonia treated with tocilizumab. Transpl. Infect. Dis. 2020;22:13348. doi: 10.1111/tid.13348.
    1. Monfared A., Dashti-Khavidaki S., Jafari R., Jafari A., Ramezanzade E., Lebadi M., Haghdar-Saheli Y., Aghajanzadeh P., Khosravi M., Movassaghi A., et al. Clinical characteristics and outcome of COVID-19 pneumonia in kidney transplant recipients in Razi hospital, Rasht, Iran. Transpl. Infect. Dis. 2020;22:e13420. doi: 10.1111/tid.13420.
    1. Nair V., Jandovitz N., Hirsch J.S., Nair G., Abate M., Bhaskaran M., Grodstein E., Berlinrut I., Hirschwerk D., Cohen S.L., et al. COVID-19 in kidney transplant recipients. Am. J. Transplant. 2020;20:1819–1825. doi: 10.1111/ajt.15967.
    1. Pierrotti L.C., Reusing J.O., Jr., Freire M.P., Machado D.J.B., Moreira R.M., Ventura C.G., Litvoc M.N., Nahas W.C., David-Neto E. COVID-19 among kidney-transplant recipients requiring hospitalization: Preliminary data and outcomes from a single-center in Brazil. Transpl. Int. 2020;33:1837–1842. doi: 10.1111/tri.13745.
    1. Rodriguez-Cubillo B., De La Higuera M.A.M., Lucena R., Franci E.V., Hurtado M., Romero N.C., Moreno A.R., Valencia D., Velo M., Fornie I.S., et al. Should cyclosporine be useful in renal transplant recipients affected by SARS-CoV-2? Am. J. Transplant. 2020;20:3173–3181. doi: 10.1111/ajt.16141.
    1. Silva F., Cipriano A., Cruz H., Tavares J., Fragoso J., Malheiro J., Almeida M., Martins L.S., Abreu M., Pedroso S., et al. SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases. Transpl. Infect. Dis. 2021;23:e13394. doi: 10.1111/tid.13394.
    1. Trujillo H., Caravaca-Fontán F., Sevillano Á., Gutiérrez E., Caro J., Gutiérrez E., Yuste C., Andrés A., Praga M. SARS-CoV-2 Infection in Hospitalized Patients with Kidney Disease. Kidney Int. Rep. 2020;5:905–909. doi: 10.1016/j.ekir.2020.04.024.
    1. Zhu L., Gong N., Liu B., Lu X., Chen D., Chen S., Shu H., Ma K., Xu X., Guo Z., et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur. Urol. 2020;78:e158. doi: 10.1016/j.eururo.2020.03.039.
    1. Deeks J.J., Dinnes J., D’Amico R., Sowden A.J., Sakarovitch C., Song F., Petticrew M., Altman D.G. Evaluating non-randomised intervention studies. Health Technol. Assess. 2003;7 doi: 10.3310/hta7270.
    1. World Health Organization WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19. [(accessed on 20 March 2021)];2020 Mar 11; Available online: .
    1. Hilbrands L.B., Duivenvoorden R., Vart P., Franssen C.F.M., Hemmelder M.H., Jager K.J., Kieneker L.M., Noordzij M., Pena M.J., de Vries H., et al. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration. Nephrol. Dial. Transplant. 2020;35:1973–1983. doi: 10.1093/ndt/gfaa261.
    1. ERA EDTA Registry 22 June 2020. [(accessed on 20 March 2021)]; Available online:
    1. Tu G., Ju M., Zheng Y., Xu M., Rong R., Zhu D., Zhu T., Luo Z. Early- and late-onset severe pneumonia after renal transplantation. J. Clin. Exp. Med. 2015;8:1324–1332.
    1. Gagliardi I., Patella G., Michael A., Serra R., Provenzano M., Andreucci M. COVID-19 and the Kidney: From Epidemiology to Clinical Practice. J. Clin. Med. 2020;9:2506. doi: 10.3390/jcm9082506.
    1. Molaei H., Khedmat L., Nemati E., Rostami Z., Saadat S.H. Iranian kidney transplant recipients with COVID-19 infection: Clinical outcomes and cytomegalovirus coinfection. Transpl. Infect. Dis. 2021;23:13455. doi: 10.1111/tid.13455.
    1. Liu J., Li S., Liu J., Liang B., Wang X., Wang H., Li W., Tong Q., Yi J., Zhao L., et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine. 2020;55:102763. doi: 10.1016/j.ebiom.2020.102763.
    1. Hu Q., Zhong Z., Xiong Y., Ye S., Wang Y., Ye Q. Management of immunosuppression in kidney transplant recipients with COVID-19 pneumonia: A summary of 41 confirmed cases reported worldwide. Transpl. Infect. Dis. 2021;23:e13425. doi: 10.1111/tid.13425.
    1. American Association for the Study of Liver Diseases Clinical Insights for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic. 23 March 2020. [(accessed on 20 March 2021)]; Available online: .
    1. Ma-Lauer Y., Zheng Y., Malešević M., Von Brunn B., Fischer G., Von Brunn A. Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication. Antivir. Res. 2020;173:104620. doi: 10.1016/j.antiviral.2019.104620.
    1. Cavagna L., Seminari E., Zanframundo G., Gregorini M., Di Matteo A., Rampino T., Montecucco C., Pelenghi S., Cattadori B., Pattonieri E.F., et al. Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy. Microorganisms. 2020;8:977. doi: 10.3390/microorganisms8070977.
    1. Shen L., Niu J., Wang C., Huang B., Wang W., Zhu N., Deng Y., Wang H., Ye F., Cen S., et al. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses. J. Virol. 2019;93:00023-19. doi: 10.1128/JVI.00023-19.
    1. Rodriguez-Morales A.J., Cardona-Ospina J.A., Gutiérrez-Ocampo E., Villamizar-Peña R., Holguin-Rivera Y., Escalera-Antezana J.P., Alvarado-Arnez L.E., Bonilla-Aldana D.K., Franco-Paredes C., Henao-Martinez A.F., et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med. Infect. Dis. 2020;34:101623. doi: 10.1016/j.tmaid.2020.101623.
    1. Kindrachuk J., Ork B., Hart B.J., Mazur S., Holbrook M.R., Frieman M.B., Traynor D., Johnson R.F., Dyall J., Kuhn J.H., et al. Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis. Antimicrob. Agents Chemother. 2015;59:1088–1099. doi: 10.1128/AAC.03659-14.
    1. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nat. Cell Biol. 1989;337:473–475. doi: 10.1038/337473a0.
    1. Harding M.W., Galat A., Uehling D.E., Schreiber S.L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989;337:473–475. doi: 10.1038/337473a0.
    1. Flanagan W.M., Corthésy B., Bram R.J., Crabtree G.R. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nat. Cell Biol. 1991;352:803–807. doi: 10.1038/352803a0.
    1. De Wilde A.H., Zevenhoven-Dobbe J.C., Van Der Meer Y., Thiel V., Narayanan K., Makino S., Snijder E.J., Van Hemert M.J. Cyclosporin A inhibits the replication of diverse coronaviruses. J. Gen. Virol. 2011;92:2542–2548. doi: 10.1099/vir.0.034983-0.
    1. Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0.
    1. Mirjalili M., Shafiekhani M., Vazin A. Coronavirus Disease 2019 (COVID-19) and Transplantation: Pharmacotherapeutic Management of Immunosuppression Regimen. Ther. Clin. Risk Manag. 2020;16:617–629. doi: 10.2147/TCRM.S256246.
    1. Horby P., Lim W.S., Emberson J.R., Mafham M., Bell J.L., Linsell L., Staplin N., Brightling C., Ustianowski A., Elmahi E., et al. Dexamethasone in Hospitalized Patients with Covid-19—Preliminary Report. N. Engl. J. Med. 2020:nejmoa2021436. doi: 10.1056/nejmoa2021436.
    1. Chihrin S., Loutfy M.R. Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome. Expert Rev. Anti-Infect. Ther. 2005;3:251–262. doi: 10.1586/14787210.3.2.251.
    1. Russell B., Moss C., George G., Santaolalla A., Cope A., Papa S., Van Hemelrijck M. Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. Ecancermedicalscience. 2020;14:1022. doi: 10.3332/ecancer.2020.1022.
    1. Sarkar S., Khanna P., Soni K.D. Are the steroids a blanket solution for COVID-19? A systematic review and meta-analysis. J. Med. Virol. 2021;93:1538–1547. doi: 10.1002/jmv.26483.
    1. Imam A., Tzukert K., Merhav H., Imam R., Abu-Gazala S., Abel R., Elhalel M.D., Khalaileh A. Practical recommendations for kidney transplantation in the COVID-19 pandemic. World J. Transplant. 2020;10:223–229. doi: 10.5500/wjt.v10.i9.223.
    1. Nashan B. Antibody Induction Therapy in Renal Transplant Patients Receiving Calcineurin-Inhibitor Immunosuppressive Regimens. BioDrugs. 2005;19:39–46. doi: 10.2165/00063030-200519010-00005.
    1. Akalin E., Sehgal V., Ames S., Hossain S., Daly L., Barbara M., Bromberg J.S. Cytomegalovirus Disease in High-Risk Transplant Recipients Despite Ganciclovir or Valganciclovir Prophylaxis. Am. J. Transplant. 2003;3:731–735. doi: 10.1034/j.1600-6143.2003.00140.x.
    1. Mourad G., Garrigue V., Squifflet J.P., Besse T., Berthoux F., Alamartine E., Durand D., Rostaing L., Lang P., Baron C., et al. Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation. 2001;72:1050–1055. doi: 10.1097/00007890-200109270-00012.
    1. Cai J., Terasaki P.I. Induction Immunosuppression Improves Long-Term Graft and Patient Outcome in Organ Transplantation: An Analysis of United Network for Organ Sharing Registry Data. Transplantation. 2010;90:1511–1515. doi: 10.1097/TP.0b013e3181fecfcb.
    1. Bamoulid J., Staeck O., Crépin T., Halleck F., Saas P., Brakemeier S., Ducloux D., Budde K. Anti-thymocyte globulins in kidney transplantation: Focus on current indications and long-term immunological side effects. Nephrol. Dial. Transplant. 2016;32:1601–1608. doi: 10.1093/ndt/gfw368.
    1. Hellemans R., Bosmans J., Abramowicz D. Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies? Am. J. Transplant. 2017;17:22–27. doi: 10.1111/ajt.13884.
    1. Fishman J.A. Infection in Solid-Organ Transplant Recipients. N. Engl. J. Med. 2007;357:2601–2614. doi: 10.1056/NEJMra064928.
    1. Fishman J.A. Infection in Organ Transplantation. Am. J. Transplant. 2017;17:856–879. doi: 10.1111/ajt.14208.
    1. Gralla J., Wiseman A.C. The Impact of IL2ra Induction Therapy in Kidney Transplantation Using Tacrolimus- and Mycophenolate-Based Immunosuppression. Transplantation. 2010;90:639–644. doi: 10.1097/TP.0b013e3181ea6788.
    1. Webster A.C., Taylor R.R., Chapman J.R., Craig J.C. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst. Rev. 2005;4:CD003961. doi: 10.1002/14651858.CD003961.pub2.
    1. Ekberg H., Tedesco-Silva H., Demirbas A., Vítko Š., Nashan B., Guerkan A., Margreiter R., Hugo C., Grinyó J.M., Frei U., et al. Reduced Exposure to Calcineurin Inhibitors in Renal Transplantation. N. Engl. J. Med. 2007;357:2562–2575. doi: 10.1056/NEJMoa067411.
    1. Favi E., Gargiulo A., Spagnoletti G., Salerno M., Silvestrini N., Valente I., Citterio F. Induction with Basiliximab Plus Thymoglobulin Is Effective and Safe in Old-for-Old Renal Transplantation: Six-Month Results of a Prospective Clinical Study. Transplant. Proc. 2010;42:1114–1117. doi: 10.1016/j.transproceed.2010.03.073.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel